{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anticancer", "Gemcitabine", "PANC-1 cells", "RAS/MEK pathways", "Vernonia amygdalina"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38111670", "DateRevised": {"Year": "2023", "Month": "12", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "13"}], "Language": ["eng"], "ELocationID": ["101872", "10.1016/j.jsps.2023.101872"], "Journal": {"ISSN": "1319-0164", "JournalIssue": {"Volume": "32", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jan"}}, "Title": "Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society", "ISOAbbreviation": "Saudi Pharm J"}, "ArticleTitle": "The ethyl acetate extract of <i>Vernonia amygdalina</i> leaf ameliorates gemcitabine effect against migration and invasion of PANC-1 cells via down-regulation the VEGF, COX<sub>2</sub>, and RAS/MEK pathways.", "Pagination": {"StartPage": "101872", "MedlinePgn": "101872"}, "Abstract": {"AbstractText": ["Individuals diagnosed with cancer often turn to the use of herbal remedies with the intention of treating and ameliorating the condition, impeding the progression of metastasis, enhancing immune function, mitigating stress, and inducing relaxation. Recently, medicinal plants were combined with conventional chemotherapy to decrease the side effects and increase the effectiveness of chemotherapy. This study showed the effectiveness of gemcitabine (Gem) was significantly increased after being used together with ethyl acetate extract obtained from <i>Vernonia amygdalina</i> (Eav) leaves. The combination doses of Eav and Gem were determined based on cytotoxic activity using the MTT assay method. The anticancer effect of this combination was identified by several parameters including the apoptosis effect, anti-migration, and anti-invasion activities of PANC-1 cells. Furthermore, this effect was explained via protein expression evaluation using immunohistochemical and flow cytometry. The Eav has a better Inhibitory Concentration 50 (IC<sub>50</sub>) than Gem of 21.19\u00a0\u00b1\u00a00.64\u00a0\u00b5g/mL and 164.78\u00a0\u00b1\u00a01.40\u00a0\u00b5g/mL. The combination of Eav and Gem at IC<sub>50</sub> (1:1) has the strongest activity than Eav and Gem alone at 500.00\u00a0\u00b5g/mL. The anti-cancer effect of this combination showed significantly increased levels of apoptosis, particularly in the early phase of 17.46\u00a0\u00b1\u00a00.35\u00a0% (p\u00a0<\u00a00.0001) than Eav and Gem alone of 7.76\u00a0\u00b1\u00a00.25\u00a0% and 7.06\u00a0\u00b1\u00a00.20\u00a0%. A similar impact was evaluated in the migration and invasion of PANC-1 cells after the combination treatment. The % relative migration and cell invasion were significantly decreased compared to the control group and Eav or Gem alone by 21.49\u00a0\u00b1\u00a00.96\u00a0% and 125.25\u00a0\u00b1\u00a05.25 cells, respectively (p\u00a0<\u00a00.0001). This study found that signature molecules of VEGF, COX2, RAS, and MEK were down-regulated after treatment. Our study suggested that the Eav ameliorates the Gem effect against PANC-1 cells through apoptosis, migration, and invasion influence via RAS/MEK pathways."], "CopyrightInformation": "\u00a9 2023 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Indonesia."}], "LastName": "Hasibuan", "ForeName": "Poppy Anjelisa Zaitun", "Initials": "PAZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical and Food Analysis, Faculty of Vocational, Universitas Sumatera Utara, Indonesia."}], "LastName": "Keliat", "ForeName": "Jane Melita", "Initials": "JM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Sumatera Utara, Indonesia."}], "LastName": "Lubis", "ForeName": "Muhammad Fauzan", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Pharmacy, Universitas Sumatera Utara, Indonesia."}], "LastName": "Nasution", "ForeName": "Annisa", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Saudi Arabia", "MedlineTA": "Saudi Pharm J", "NlmUniqueID": "9705695", "ISSNLinking": "1319-0164"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alara O.R., Abdurahman N.H., Mudalip S.K.A., Olalere O.A. Phytochemical and pharmacological properties of Vernonia amygdalina: a review. J. Chem. Eng. Indus. Biotechnol. 2017;2(1):80\u201396."}, {"Citation": "Annese T., Tamma R., Ruggieri S., Ribatti D. Angiogenesis in pancreatic cancer: pre-clinical and clinical studies. Cancers. 2019;11(3):381.", "ArticleIdList": ["PMC6468440", "30889903"]}, {"Citation": "Ashrafizadeh M., Bakhoda M.R., Bahmanpour Z., Ilkhani K., Zarrabi A., Makvandi P., Mirzaei H. Apigenin as tumor suppressor in cancers: Biotherapeutic activity, nanodelivery, and mechanisms with emphasis on pancreatic cancer. Front. Chem. 2020;8:829.", "ArticleIdList": ["PMC7593821", "33195038"]}, {"Citation": "Ashrafizadeh M., Zarrabi A., Hashemi F., Moghadam E.R., Hashemi F., Entezari M., Najafi M. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sci. 2020;256", "ArticleIdList": ["32593707"]}, {"Citation": "Bannoura S.F., Uddin M.H., Nagasaka M., Fazili F., Al-Hallak M.N., Philip P.A., Azmi A.S. Targeting KRAS in pancreatic cancer: new drugs on the horizon. Cancer Metastasis Rev. 2021:1\u201317.", "ArticleIdList": ["PMC8556325", "34499267"]}, {"Citation": "Bestari, R., Ichwan, M. F., Mustofa, M., & Satria, D. (2017, December). Anticancer activity of Vernonia amygdalina del. extract on WiDr colon cancer cell line. In 2nd Public Health International Conference (PHICo 2017) (pp. 1-5). Atlantis Press."}, {"Citation": "Burhan A., Kamaruddin M., Ahmad R., Marzuki I. Anticancer and cytotoxic potentials of Vernonia amygdalina Delile on WiDr cell lines. Phytopharmacol. Res. J. 2022;1(1):1\u20137."}, {"Citation": "Buscail L., Bournet B., Cordelier P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 2020;17(3):153\u2013168.", "ArticleIdList": ["32005945"]}, {"Citation": "Bylsma L.C., Gillezeau C., Garawin T.A., Kelsh M.A., Fryzek J.P., Sangar\u00e9 L., Lowe K.A. Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer Med. 2020;9(3):1044\u20131057.", "ArticleIdList": ["PMC6997095", "31856410"]}, {"Citation": "Chen, X. Y., Zhou, J., Luo, L. P., Han, B., Li, F., Chen, J. Y., ... & Yu, X. P. (2015). Black rice anthocyanins suppress metastasis of breast cancer cells by targeting RAS/RAF/MAPK pathway. BioMed research international, 2015.", "ArticleIdList": ["PMC4663286", "26649302"]}, {"Citation": "Conroy T., Hammel P., Hebbar M., Ben Abdelghani M., Wei A.C., Raoul J.L., Bachet J.B. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N. Engl. J. Med. 2018;379(25):2395\u20132406.", "ArticleIdList": ["30575490"]}, {"Citation": "Di Magliano M.P., Logsdon C.D. Roles for KRAS in pancreatic tumor development and progression. Gastroenterology. 2013;144(6):1220\u20131229.", "ArticleIdList": ["PMC3902845", "23622131"]}, {"Citation": "Evbuomwan L., Chukwuka E.P., Obazenu E.I., Ilevbare L. Antibacterial activity of Vernonia amygdalina leaf extracts against multidrug resistant bacterial isolates. J. Appl. Sci. Environ. Manag. 2018;22(1):17\u201321."}, {"Citation": "Fauzan M.L., Hasibuan P.A.Z., Harahap U. Phytocemicals screening and cell cycle arrest activity of n-hexane extract of Vernonia amygdalina Delile leaves against pancreatic cancer cell line. Asian J. Pharma. Res. Develop. 2019;7(4):12\u201316."}, {"Citation": "Harahap U., Hasibuan P.A.Z., Sitorus P., Arfian N., Satria D. Antimigration activity of an ethylacetate fraction of Zanthoxylum acanthopodium DC. fruits in 4T1 breast cancer cells. Asian Pac. J. Cancer Prev. 2018;19(2):565.", "ArticleIdList": ["PMC5980951", "29481017"]}, {"Citation": "Hasibuan P.A.Z., Ilyas S. Antioxidant and cytotoxic activities of Plectranthus amboinicus (Lour.) Spreng. extracts. Int. J. Pharm. Teach. Pract. 2013;4(3):1\u20133."}, {"Citation": "Hasibuan P.A.Z., Munir D., Pertiwi D., Satria D., Lubis M.F. Flavonoids constituent analysis and cell cycle inhibition activity of ethylacetate extract of vernonia amygdalina delile. Leaves on lung cancer cell line. Leaves on lung cancer cell line. Rasayan J. Chem. 2020;13(4):2577\u20132581."}, {"Citation": "Hasibuan P.A.Z., Harahap U., Sitorus P., Lubis M.F., Satria D. In-silico analysis of Vernonioside D and Vernonioside E from Vernonia Amygdalina Delile. leaves as inhibitor of Epidermal Growth Factor Receptor (EGFR) and Mammalian Target of Rapamycin (mTOR) Rasayan J. Chem. 2021;14(3):1539\u20131543."}, {"Citation": "Hasibuan P.A.Z., Sumaiyah S. The anti-proliferative and pro-apoptotic properties of ethanol Plectranthus amboinicus (Lour.) Spreng. leaves ethanolic extract nanoparticles on T47D cell lines. Asian Pacific journal of cancer prevention. APJCP. 2019;20(3):897.", "ArticleIdList": ["PMC6825766", "30912412"]}, {"Citation": "Hasibuan P.A.Z., Harahap U., Sitorus P., Satria D. The anticancer activities of Vernonia amygdalina Delile. Leaves on 4T1 breast cancer cells through phosphoinositide 3-kinase (PI3K) pathway. Heliyon. 2020;6(7):e04449.", "ArticleIdList": ["PMC7371756", "32715129"]}, {"Citation": "Hii L.W., Lim S.H.E., Leong C.O., Chin S.Y., Tan N.P., Lai K.S., Mai C.W. The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: Downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma. BMC Complement. Altern. Med. 2019;19(1):1\u201313.", "ArticleIdList": ["PMC6744713", "31521140"]}, {"Citation": "Hu J.X., Zhao C.F., Chen W.B., Liu Q.C., Li Q.W., Lin Y.Y., Gao F. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J. Gastroenterol. 2021;27(27):4298.", "ArticleIdList": ["PMC8316912", "34366606"]}, {"Citation": "Huang M., Lu J.J., Ding J. Natural products in cancer therapy: Past, present and future. Nat. Prod. Bioprospect. 2021;11:5\u201313.", "ArticleIdList": ["PMC7933288", "33389713"]}, {"Citation": "Jamshed M.B., Munir F., Shahid N., Sadiq U., Muhammad S.A., Ghanem N.B., Zhang Q. Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer. Am. J. Physiol.-Gastrointest. Liver Physiol. 2020;318(1):G109\u2013G119.", "ArticleIdList": ["31736340"]}, {"Citation": "Johnson W., Tchounwou P.B., Yedjou C.G. Therapeutic mechanisms of Vernonia amygdalina delile in the treatment of prostate cancer. Molecules. 2017;22(10):1594.", "ArticleIdList": ["PMC5661957", "28937624"]}, {"Citation": "Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., ... & Bishayee, A. (2021, February). Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. In Seminars in cancer biology (Vol. 69, pp. 5-23). Academic Press.", "ArticleIdList": ["31421264"]}, {"Citation": "King J.C., Lu Q.Y., Li G., Moro A., Takahashi H., Chen M., Hines O.J. Evidence for activation of mutated p53 by apigenin in human pancreatic cancer. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 2012;1823(2):593\u2013604.", "ArticleIdList": ["PMC3277744", "22227579"]}, {"Citation": "Lakkakula, B. V. K. S., Farran, B., Lakkakula, S., Peela, S., Yarla, N. S., Bramhachari, P. V., ... & Nagaraju, G. P. (2019, June). Small molecule tyrosine kinase inhibitors and pancreatic cancer\u2014Trials and troubles. In Seminars in cancer biology (Vol. 56, pp. 149-167). Academic Press.", "ArticleIdList": ["30314681"]}, {"Citation": "Li X.L., Yin Q., Wang W., Ma R.H., Ni Z.J., Thakur K., Wei Z.J. Effect of ginsenoside CK combined with cisplatin on the proliferation and migration of human cervical cancer HeLa cells via Ras/ERK/MAPK pathway. J. Funct. Foods. 2023;102"}, {"Citation": "Li Z., Zhang Y., Chen L., Li H. The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2. Food Funct. 2018;9(5):3018\u20133027.", "ArticleIdList": ["29770817"]}, {"Citation": "Lifiani R., Harahap U., Hasibuan P.A.Z., Satria D. Anticancer effect of african leaves (vernonia amygdalina del). to T47D cell resistant. Asian J. Pharma. Clin. Res. 2018;11(1):2\u20135."}, {"Citation": "Lubis M.F., Syahputra H., Illian D.N., Kaban V.E. Antioxidant activity and nephroprotective effect of Lansium parasiticum leaves in doxorubicin-induced rats. J. Res. Pharm. (Online) 2022;26(3):565\u2013573."}, {"Citation": "Lubis M.F., Hasibuan P.A.Z., Syahputra H., Surbakti C., Astyka R. Saurauia vulcani (Korth.) as herbal medicine potential from North Sumatera, Indonesia: A literature review. Heliyon. 2022:e09249.", "ArticleIdList": ["PMC9010632", "35434390"]}, {"Citation": "Lubis M.F., Hasibuan P.A.Z., Harahap U., Satria D., Syahputra H., Muhammad M., Astyka R. The molecular approach of natural products as pancreatic cancer treatment: A review. Rasayan J. Chem. 2022;15(2):1362\u20131377."}, {"Citation": "Lubis M.F., Hasibuan P.A.Z., Syahputra H., Astyka R., Baruna I. Phytochemical profile and pharmacological activity of Vernonia amygdalina Delile stem bark extracts using different solvent extraction. Open Access Macedonian J. Med. Sci. 2022;10(A):860\u2013866."}, {"Citation": "Lubis M.F., Hasibuan P.A.Z., Syahputra H., Keliat J.M., Kaban V.E., Astyka R. Duku (Lansium domesticum) leaves extract induces cell cycle arrest and apoptosis of HepG2 cells via PI3K/Akt pathways. Trends Sci. 2023;20(2):6437."}, {"Citation": "Luo C., Wang Y., Wei C., Chen Y., Ji Z. The anti migration and anti invasion effects of Bruceine D in human triple negative breast cancer MDA MB 231 cells. Exp. Ther. Med. 2020;19(1):273\u2013279.", "ArticleIdList": ["PMC6909795", "31853299"]}, {"Citation": "McGuigan A., Kelly P., Turkington R.C., Jones C., Coleman H.G., McCain R.S. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J. Gastroenterol. 2018;24(43):4846.", "ArticleIdList": ["PMC6250924", "30487695"]}, {"Citation": "Miller A.L., Garcia P.L., Yoon K.J. Developing effective combination therapy for pancreatic cancer: An overview. Pharmacol. Res. 2020;155", "ArticleIdList": ["PMC7365261", "32135247"]}, {"Citation": "Oladele J.O., Oyeleke O.M., Oladele O.T., Oladiji A.T. Covid-19 treatment: Investigation on the phytochemical constituents of Vernonia amygdalina as potential Coronavirus-2 inhibitors. Comput. Toxicol. 2021;18", "ArticleIdList": ["PMC7889463", "33619460"]}, {"Citation": "Oyugi D.A., Luo X., Lee K.S., Hill B., Izevbigie E.B. Activity markers of the anti-breast carcinoma cell growth fractions of Vernonia amygdalina extracts. Exp. Biol. Med. 2009;234(4):410\u2013417.", "ArticleIdList": ["PMC2852581", "19176872"]}, {"Citation": "Pak P.J., Lee D.G., Sung J.H., Jung S.H., Han T.Y., Park S.H., Chung N. Synergistic effect of the herbal mixture C5E on gemcitabine treatment in PANC 1 cells. Mol. Med. Rep. 2021;23(5):1\u20139.", "ArticleIdList": ["PMC7974510", "33760105"]}, {"Citation": "Park W., Chawla A., O\u2019Reilly E.M. Pancreatic cancer: A review. Jama. 2021;326(9):851\u2013862.", "ArticleIdList": ["PMC9363152", "34547082"]}, {"Citation": "Paudel M.R., Chand M.B., Pant B., Pant B. Assessment of antioxidant and cytotoxic activities of extracts of Dendrobium crepidatum. Biomolecules. 2019;9(9):478.", "ArticleIdList": ["PMC6770461", "31547263"]}, {"Citation": "Rosidah, R., Yuandani, Y., Widjaja, S. S., Auliafendri, N., Lubis, M. F., Muhammad, M., & Satria, D. (2021). Phytochemicals Analysis and Immunomodulatory Activity of Saurauia vulcani Korth. Leaves Extracts Towards Raw 264.7 Cell."}, {"Citation": "Sari D.P., Basyuni M., Hasibuan P.A.Z., Wati R. The inhibition of polyisoprenoids from Nypa fruticans leaves on cyclooxygenase 2 expression of widr colon cancer cells. Asian J. Pharm. Clin. Res. 2018;11(8):156."}, {"Citation": "Saung M.T., Zheng L. Current standards of chemotherapy for pancreatic cancer. Clin. Ther. 2017;39(11):2125\u20132134.", "ArticleIdList": ["PMC5705388", "28939405"]}, {"Citation": "Schultheis B., Reuter D., Ebert M.P., Siveke J., Kerkhoff A., Berdel W.E., Strumberg D. Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: A multicenter, randomized phase IIb study. Ann. Oncol. 2017;28(10):2429\u20132435.", "ArticleIdList": ["28961832"]}, {"Citation": "Shankar S., Tien J.C.Y., Siebenaler R.F., Chugh S., Dommeti V.L., Zelenka-Wang S., Chinnaiyan A.M. An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development. Nat. Commun. 2020;11(1):2817.", "ArticleIdList": ["PMC7272436", "32499547"]}, {"Citation": "Shi J., Liu F., Zhang W., Liu X., Lin B., Tang X. Epigallocatechin-3-gallate inhibits nicotine induced migration and invasion by the suppression of angiogenesis and epithelial mesenchymal transition in non-small cell lung cancer cells. Oncol. Rep. 2015;33(6):2972\u20132980.", "ArticleIdList": ["25845434"]}, {"Citation": "Springfeld C., J\u00e4ger D., B\u00fcchler M.W., Strobel O., Hackert T., Palmer D.H., Neoptolemos J.P. Chemotherapy for pancreatic cancer. La Presse Medicale. 2019;48(3):e159\u2013e174.", "ArticleIdList": ["30879894"]}, {"Citation": "Suker M., Beumer B.R., Sadot E., Marthey L., Faris J.E., Mellon E.A., Koerkamp B.G. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016;17(6):801\u2013810.", "ArticleIdList": ["PMC5527756", "27160474"]}, {"Citation": "Tamburrino A., Piro G., Carbone C., Tortora G., Melisi D. Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy. Front. Pharmacol. 2013;4:56.", "ArticleIdList": ["PMC3639407", "23641216"]}, {"Citation": "Tan B.L., Norhaizan M.E. Curcumin combination chemotherapy: The implication and efficacy in cancer. Molecules. 2019;24(14):2527.", "ArticleIdList": ["PMC6680685", "31295906"]}, {"Citation": "Thongnest S., Chawengrum P., Keeratichamroen S., Lirdprapamongkol K., Eurtivong C., Boonsombat J., Ruchirawat S. Vernodalidimer L, a sesquiterpene lactone dimer from Vernonia extensa and anti-tumor effects of vernodalin, vernolepin, and vernolide on HepG2 liver cancer cells. Bioorg. Chem. 2019;92", "ArticleIdList": ["31445193"]}, {"Citation": "Wang J., Liu Y., Zhao J., Zhang W., Pang X. Saponins extracted from by-product of Asparagus officinalis L. suppress tumour cell migration and invasion through targeting Rho GTPase signalling pathway. J. Sci. Food Agric. 2013;93(6):1492\u20131498.", "ArticleIdList": ["23450726"]}, {"Citation": "Wang H., Luo Y., Qiao T., Wu Z., Huang Z. Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion. J. Ovarian Res. 2018;11:1\u201312.", "ArticleIdList": ["PMC6241043", "30454003"]}, {"Citation": "Wong F.C., Woo C.C., Hsu A., Tan B.K.H. The anti-cancer activities of Vernonia amygdalina extract in human breast cancer cell lines are mediated through caspase-dependent and p53-independent pathways. PLoS One. 2013;8(10):e78021.", "ArticleIdList": ["PMC3812032", "24205071"]}, {"Citation": "Xiao Y., Liu Y., Gao Z., Li X., Weng M., Shi C., Sun L. Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling. Aging (Albany NY) 2021;13(22):24753.", "ArticleIdList": ["PMC8660603", "34821587"]}, {"Citation": "Yedjou C., Izevbigie E., Tchounwou P. Preclinical assessment of Vernonia amygdalina leaf extracts as DNA damaging anti-cancer agent in the management of breast cancer. Int. J. Environ. Res. Public Health. 2008;5(5):337\u2013341.", "ArticleIdList": ["PMC3699992", "19151427"]}, {"Citation": "Yedjou C.G., Izevbigie E.B., Tchounwou P.B. Vernonia amygdalina\u2014induced growth arrest and apoptosis of breast cancer (MCF-7) cells. Pharmacol. Pharm. 2013;4(1)", "ArticleIdList": ["PMC3864043", "24353904"]}, {"Citation": "Yu, J., DRISkO, J. E. A. N. N. E., & Chen, Q. (2013). Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira. Oncology reports, 30(1), 149-156.", "ArticleIdList": ["23674070"]}, {"Citation": "Yusoff, S. F., Haron, F. F., Tengku Muda Mohamed, M., Asib, N., Sakimin, S. Z., Abu Kassim, F., & Ismail, S. I. (2020). Antifungal activity and phytochemical screening of Vernonia amygdalina extract against Botrytis cinerea causing gray mold disease on tomato fruits. Biology, 9(9), 286.", "ArticleIdList": ["PMC7563699", "32932993"]}, {"Citation": "Zakaria Z., Zulkifle M.F., Hasan W.A.N.W., Azhari A.K., Raub S.H.A., Eswaran J., Husain S.N.A.S. Epidermal growth factor receptor (EGFR) gene alteration and protein overexpression in Malaysian triple-negative breast cancer (TNBC) cohort. OncoTargets Ther. 2019;12:7749.", "ArticleIdList": ["PMC6759283", "31571924"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "8", "Day": "18"}, {"Year": "2023", "Month": "11", "Day": "12"}, {"Year": "2023", "Month": "12", "Day": "19", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "19", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "12", "Day": "19", "Hour": "3", "Minute": "55"}, {"Year": "2023", "Month": "11", "Day": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38111670", "PMC10727942", "10.1016/j.jsps.2023.101872", "S1319-0164(23)00367-5"]}}], "PubmedBookArticle": []}